Stock listing
KRX:048410 Hyundai Bioscience Co. Ltd. (현대바이오) 주가
Follow Hyundai Bioscience Co. Ltd. into a list and get an email when it puts out news.
Share price · KRX:048410
₩6,070.00 KRW +20.00 (+0.3%)
Close on Nov 20, 2026
- Day range
- ₩6,040.00 – ₩6,390.00 KRWNov 20, 2026
- Volume
- 908,288 sharesNov 20, 2026
- Market cap
- ₩585.8B KRWAt the close on Nov 20, 2026 · price × 96.50M shares outstanding
- 52-week range
- ₩4,565.00 – ₩21,500.00 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₩7.09B KRWMedian day 838,579 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:048410 · KRW, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₩6,070.00 | +20.00 | +0.3% | ₩6,250.00 | ₩6,390.00 | ₩6,040.00 | 908,288 | |
| ₩6,050.00 | +80.00 | +1.3% | ₩5,980.00 | ₩6,370.00 | ₩5,810.00 | 840,223 | |
| ₩5,970.00 | -200.00 | -3.2% | ₩6,390.00 | ₩6,420.00 | ₩5,930.00 | 868,661 | |
| ₩6,170.00 | 0.00 | 0.0% | ₩6,230.00 | ₩6,440.00 | ₩6,100.00 | 892,411 | |
| ₩6,170.00 | +500.00 | +8.8% | ₩5,720.00 | ₩6,850.00 | ₩5,720.00 | 3,168,547 | |
| ₩5,670.00 | -170.00 | -2.9% | ₩5,810.00 | ₩5,810.00 | ₩5,570.00 | 424,786 | |
| ₩5,840.00 | +290.00 | +5.2% | ₩5,530.00 | ₩5,870.00 | ₩5,510.00 | 585,492 | |
| ₩5,550.00 | +140.00 | +2.6% | ₩5,610.00 | ₩5,750.00 | ₩5,430.00 | 474,605 | |
| ₩5,410.00 | -230.00 | -4.1% | ₩5,650.00 | ₩5,800.00 | ₩5,400.00 | 672,679 | |
| ₩5,640.00 | +210.00 | +3.9% | ₩5,010.00 | ₩5,830.00 | ₩5,010.00 | 1,042,356 | |
| ₩5,430.00 | -20.00 | -0.4% | ₩5,520.00 | ₩5,840.00 | ₩5,310.00 | 828,859 | |
| ₩5,450.00 | +220.00 | +4.2% | ₩5,330.00 | ₩5,450.00 | ₩5,070.00 | 713,414 | |
| ₩5,230.00 | -300.00 | -5.4% | ₩5,460.00 | ₩5,460.00 | ₩5,210.00 | 594,368 | |
| ₩5,530.00 | +160.00 | +3.0% | ₩5,370.00 | ₩5,820.00 | ₩5,340.00 | 833,645 | |
| ₩5,370.00 | -300.00 | -5.3% | ₩5,590.00 | ₩5,650.00 | ₩5,240.00 | 1,057,310 | |
| ₩5,670.00 | -200.00 | -3.4% | ₩5,870.00 | ₩5,910.00 | ₩5,590.00 | 774,194 | |
| ₩5,870.00 | +50.00 | +0.9% | ₩5,840.00 | ₩6,120.00 | ₩5,790.00 | 1,179,192 | |
| ₩5,820.00 | -120.00 | -2.0% | ₩5,980.00 | ₩6,240.00 | ₩5,720.00 | 1,229,814 | |
| ₩5,940.00 | -440.00 | -6.9% | ₩6,200.00 | ₩6,230.00 | ₩5,820.00 | 863,840 | |
| ₩6,380.00 | +220.00 | +3.6% | ₩6,100.00 | ₩6,430.00 | ₩6,000.00 | 744,047 | |
| ₩6,160.00 | -180.00 | -2.8% | ₩6,220.00 | ₩6,330.00 | ₩6,120.00 | 489,422 | |
| ₩6,340.00 | -350.00 | -5.2% | ₩6,780.00 | ₩6,980.00 | ₩6,210.00 | 888,514 | |
| ₩6,690.00 | -120.00 | -1.8% | ₩6,740.00 | ₩6,950.00 | ₩6,540.00 | 546,722 | |
| ₩6,810.00 | +260.00 | +4.0% | ₩6,450.00 | ₩6,970.00 | ₩6,400.00 | 634,211 | |
| ₩6,550.00 | +460.00 | +7.6% | ₩6,070.00 | ₩6,740.00 | ₩5,990.00 | 836,935 | |
| ₩6,090.00 | -340.00 | -5.3% | ₩6,200.00 | ₩6,320.00 | ₩5,880.00 | 938,768 | |
| ₩6,430.00 | +10.00 | +0.2% | ₩6,360.00 | ₩6,570.00 | ₩6,240.00 | 569,156 | |
| ₩6,420.00 | +80.00 | +1.3% | ₩6,120.00 | ₩6,560.00 | ₩6,050.00 | 833,349 | |
| ₩6,340.00 | -590.00 | -8.5% | ₩6,870.00 | ₩7,090.00 | ₩6,330.00 | 920,541 | |
| ₩6,930.00 | -360.00 | -4.9% | ₩7,270.00 | ₩7,340.00 | ₩6,820.00 | 1,092,913 | |
| ₩7,290.00 | +140.00 | +2.0% | ₩7,150.00 | ₩7,420.00 | ₩7,080.00 | 1,314,546 | |
| ₩7,150.00 | +100.00 | +1.4% | ₩7,080.00 | ₩7,380.00 | ₩7,020.00 | 999,361 | |
| ₩7,050.00 | 0.00 | 0.0% | ₩7,070.00 | ₩7,370.00 | ₩7,040.00 | 1,195,843 | |
| ₩7,050.00 | +150.00 | +2.2% | ₩6,900.00 | ₩7,100.00 | ₩6,830.00 | 1,269,517 | |
| ₩6,900.00 | +70.00 | +1.0% | ₩6,930.00 | ₩7,040.00 | ₩6,830.00 | 798,463 | |
| ₩6,830.00 | +20.00 | +0.3% | ₩6,790.00 | ₩6,900.00 | ₩6,560.00 | 759,075 | |
| ₩6,810.00 | -40.00 | -0.6% | ₩6,930.00 | ₩7,140.00 | ₩6,810.00 | 784,396 | |
| ₩6,850.00 | +20.00 | +0.3% | ₩6,830.00 | ₩7,070.00 | ₩6,740.00 | 611,506 | |
| ₩6,830.00 | -260.00 | -3.7% | ₩7,080.00 | ₩7,250.00 | ₩6,820.00 | 1,016,184 | |
| ₩7,090.00 | +290.00 | +4.3% | ₩6,830.00 | ₩7,110.00 | ₩6,780.00 | 997,885 | |
| ₩6,800.00 | +140.00 | +2.1% | ₩6,790.00 | ₩6,890.00 | ₩6,680.00 | 884,018 | |
| ₩6,660.00 | -150.00 | -2.2% | ₩6,800.00 | ₩7,250.00 | ₩6,630.00 | 1,199,416 | |
| ₩6,810.00 | +390.00 | +6.1% | ₩6,420.00 | ₩6,970.00 | ₩6,300.00 | 1,633,864 | |
| ₩6,420.00 | -190.00 | -2.9% | ₩6,470.00 | ₩6,660.00 | ₩6,330.00 | 883,881 | |
| ₩6,610.00 | -90.00 | -1.3% | ₩6,510.00 | ₩6,780.00 | ₩6,000.00 | 1,464,948 | |
| ₩6,700.00 | -530.00 | -7.3% | ₩7,200.00 | ₩7,200.00 | ₩6,590.00 | 1,494,108 | |
| ₩7,230.00 | +100.00 | +1.4% | ₩7,130.00 | ₩7,650.00 | ₩6,940.00 | 2,898,602 | |
| ₩7,130.00 | +870.00 | +13.9% | ₩6,200.00 | ₩7,730.00 | ₩6,140.00 | 10,090,029 | |
| ₩6,260.00 | -20.00 | -0.3% | ₩6,280.00 | ₩6,390.00 | ₩6,130.00 | 647,387 | |
| ₩6,280.00 | +70.00 | +1.1% | ₩6,270.00 | ₩6,410.00 | ₩6,180.00 | 816,303 | |
| ₩6,210.00 | +160.00 | +2.6% | ₩6,110.00 | ₩6,220.00 | ₩5,780.00 | 874,205 | |
| ₩6,050.00 | -30.00 | -0.5% | ₩6,200.00 | ₩6,430.00 | ₩5,990.00 | 806,335 | |
| ₩6,080.00 | -310.00 | -4.9% | ₩6,250.00 | ₩6,350.00 | ₩6,080.00 | 640,629 | |
| ₩6,390.00 | -190.00 | -2.9% | ₩6,520.00 | ₩6,550.00 | ₩6,330.00 | 627,297 | |
| ₩6,580.00 | +40.00 | +0.6% | ₩6,470.00 | ₩6,630.00 | ₩6,320.00 | 753,825 | |
| ₩6,540.00 | +110.00 | +1.7% | ₩6,430.00 | ₩6,570.00 | ₩6,310.00 | 607,613 | |
| ₩6,430.00 | -150.00 | -2.3% | ₩6,500.00 | ₩6,980.00 | ₩6,330.00 | 1,216,840 | |
| ₩6,580.00 | +30.00 | +0.5% | ₩6,560.00 | ₩6,735.00 | ₩6,380.00 | 933,328 | |
| ₩6,550.00 | -110.00 | -1.7% | ₩6,660.00 | ₩6,710.00 | ₩6,260.00 | 763,295 | |
| ₩6,660.00 | +10.00 | +0.2% | ₩6,910.00 | ₩7,070.00 | ₩6,600.00 | 673,364 | |
| ₩6,650.00 | -440.00 | -6.2% | ₩6,990.00 | ₩6,990.00 | ₩6,590.00 | 686,895 | |
| ₩7,090.00 | -70.00 | -1.0% | ₩7,440.00 | ₩7,650.00 | ₩7,050.00 | 637,889 |
Splits
5 splits since 2004 · KRX:048410 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 2-for-1 | Split | |
| 72-for-67 | Split | |
| 1-for-10 | Consolidation | |
| 1-for-30 | Consolidation | |
| 2-for-1 | Split |
- Ticker
- KRX:048410
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- KRX
- Currency
- KRW
Latest news
Hyundai Bioscience Co. Ltd. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 2 in all · newest May 24, 2021 · oldest 2021
Valuation
EV/sales 166× against a median of 26.3×: 4th lowest of 6 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₩550.2B KRW
- P/E
- Loss
- EV/sales
- 166×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 5.7×
- Gross margin
- −6.6%
- Operating margin
- −580.1%
- Net margin
- −861.5%
- Debt to equity
- 0.1×
- Beta
- No index for this market yet
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Hyundai Bioscience Co. Ltd. · KRX:048410 | US$435.2M | US$408.8M | n/a | 166× | n/a | 5.7× | −861.5% | 0.1× | n/a |
| CytomX Therapeutics, Inc. · NASDAQ:CTMX | US$442.5M | US$98.96M | n/a | 7.0× | n/a | 1.6× | −609.0% | 0.0× | 1.21 |
| Capricor Therapeutics, Inc. · NASDAQ:CAPR | US$441.3M | US$335.9M | n/a | n/a | n/a | 2.1× | n/a | 0.4× | 0.94 |
| Hansa Biopharma AB · OMXSTO:HNSA | US$440.9M | US$488.0M | n/a | 26.3× | n/a | n/a | −406.5% | n/a | n/a |
| Shanghai MicuRx Pharmaceutical Co., Ltd. Class A · SSE:688373 | US$439.3M | US$408.1M | n/a | 16.2× | n/a | 19.4× | −57.0% | 0.9× | n/a |
| Clarity Pharmaceuticals Ltd. · ASX:CU6 | US$437.1M | US$239.0M | n/a | n/a | n/a | 3.5× | n/a | 0.0× | n/a |
| Oculis Holding AG · NASDAQ:OCS | US$434.8M | US$184.3M | n/a | 22,112× | n/a | 1.8× | n/a | 0.0× | 0.99 |
| Indaptus Therapeutics, Inc. · NASDAQ:INDP | US$433.2M | US$402.6M | n/a | n/a | n/a | 41.9× | n/a | 0.0× | 1.77 |
| Rznomics Inc. · KRX:476830 | US$432.5M | US$406.0M | n/a | n/a | n/a | 12.5× | n/a | 0.0× | n/a |
| LongBio Pharma (Suzhou) Co., Ltd. Class H · HKEX:1779 | US$430.7M | US$402.0M | n/a | n/a | n/a | 20.4× | n/a | 0.0× | n/a |
| Ovid Therapeutics Inc. · NASDAQ:OVID | US$429.7M | US$305.4M | n/a | 210× | n/a | 2.2× | n/a | 0.1× | 1.37 |
| Median of the others | US$436.0M | US$369.0M | 26.3× | 3.5× | −406.5% | 0.0× | 1.21 |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q1 2026 | May 13, 2026 · Before open | −7.2% |
| Q4 2025 | Mar 16, 2026 · Before open | −5.6% |
| Q3 2025 | Nov 12, 2025 · Before open | +6.3% |
| Q2 2025 | Aug 12, 2025 · Before open | +0.7% |
| Q1 2025 | May 15, 2025 · Before open | −1.1% |
| Q3 2024 | Nov 12, 2024 · After close | −0.9% |
| Q2 2024 | Aug 14, 2024 · After close | +3.6% |
| Q1 2024 | May 16, 2024 · After close | +1.4% |
| Q4 2023 | Mar 14, 2024 · Before open | −1.9% |
| Q3 2023 | Nov 14, 2023 · After close | −3.4% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q2 2023 | Aug 11, 2023 · After close | −9.4% |
| Q1 2023 | May 15, 2023 · After close | +2.1% |
| Q4 2022 | Feb 27, 2023 · After close | +2.9% |
| Q3 2022 | Nov 14, 2022 · After close | +5.4% |
| Q2 2022 | Aug 16, 2022 · Before open | −2.4% |
| Q1 2022 | May 16, 2022 · Before open | +1.1% |
| Q4 2021 | Feb 24, 2022 · Before open | −6.8% |
| Q3 2021 | Nov 15, 2021 | −1.6% |
| Quarter to Jun 30, 2021 | Aug 17, 2021 | +5.7% |
| Quarter to Mar 31, 2021 | May 17, 2021 | −6.9% |
Financials
Annual, in KRW
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.52B | 15.1B | 9.48B | 7.85B | 9.24B | 12.5B | 30.1B | 31.2B | 32.0B | 36.1B |
| Cost of revenue | 3.27B | 3.18B | 4.44B | 5.17B | 5.72B | 5.95B | 16.0B | 16.9B | 17.1B | 24.1B |
| Gross profit | 243.6M | 11.9B | 5.04B | 2.68B | 3.52B | 6.56B | 14.1B | 14.3B | 14.8B | 12.0B |
| Research and development | 7.60B | 3.06B | 6.40B | 16.5B | 4.76B | 1.97B | 1.29B | 1.70B | 2.05B | 2.11B |
| Selling, general and administrative | 5.44B | 7.91B | 7.91B | 11.8B | 6.90B | 6.38B | 7.61B | 9.94B | 10.8B | 16.4B |
| Operating income | -18.2B | 791.0M | -14.6B | -18.0B | -17.3B | -7.37B | 2.56B | 2.15B | 1.46B | -6.96B |
| Depreciation and amortization | 1.31B | 633.8M | 1.11B | 1.29B | 1.48B | 3.78B | 3.81B | 1.82B | 1.71B | 982.8M |
| EBITDA | -16.9B | 1.42B | -13.4B | -16.7B | -15.8B | -3.59B | 6.37B | 3.97B | 3.17B | -5.98B |
| Interest expense | 2.43B | 2.31B | 314.6M | 448.7M | 3.00B | 1.13B | 0 | 0 | 0 | 0 |
| Income before tax | -22.1B | -6.93B | -14.5B | -16.6B | -19.8B | -8.38B | 1.29B | 3.26B | 1.21B | -8.15B |
| Income tax | 326.5M | 178.8M | 150.2M | -8.45M | -79.3M | |||||
| Net income | -22.1B | -6.93B | -14.5B | -15.8B | -20.1B | -8.61B | 767.2M | 2.62B | 1.22B | -8.07B |
| Earnings per share, basic | -230.41 | -87.01 | -364.25 | -398.36 | -518.69 | -239.65 | 22.15 | 77.64 | 37.40 | -266.38 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 22.3B | 3.66B | 1.81B | 2.73B | 9.19B | 19.2B | 5.56B | 3.16B | 4.85B | 9.74B |
| Short-term investments | 17.7B | 10.0B | 16.0B | 13.0B | 1.50B | 2.66B | 3.00B | |||
| Receivables | 2.32B | 247.2M | 446.2M | 1.28B | 7.63B | 11.0B | 19.4B | 25.9B | 22.5B | 14.9B |
| Inventory | 1.14B | 1.08B | 2.59B | 2.95B | 3.35B | 4.21B | 6.08B | 4.18B | 5.88B | 6.66B |
| Current assets | 44.0B | 6.81B | 15.2B | 24.0B | 34.9B | 41.9B | 33.3B | 35.7B | 36.4B | 37.7B |
| Property, plant and equipment | 6.38B | 6.07B | 6.67B | 7.20B | 8.37B | 9.44B | 10.1B | |||
| Total assets | 130.7B | 67.7B | 52.8B | 67.3B | 80.5B | 92.3B | 63.2B | 54.0B | 49.5B | 53.4B |
| Accounts payable | 498.7M | 555.3M | 430.5M | 686.7M | 191.6M | 178.2M | 827.8M | 389.5M | 603.8M | 3.45B |
| Current liabilities | 19.5B | 27.5B | 6.95B | 8.38B | 16.7B | 9.58B | 14.5B | 11.4B | 18.5B | 27.9B |
| Long-term debt | 0 | 111.1M | 29.1B | 1.00B | 1.50B | 7.01B | ||||
| Total debt | 35.9B | 5.49B | 6.04B | 15.3B | ||||||
| Total liabilities | 20.0B | 28.3B | 7.52B | 9.09B | 19.0B | 41.1B | 16.2B | 13.5B | 18.6B | 35.2B |
| Shareholders' equity | 110.7B | 39.4B | 45.3B | 58.2B | 61.6B | 51.2B | 47.0B | 40.5B | 30.9B | 18.2B |
| Shares outstanding | 96.0M | 79.6M | 39.8M | 39.7M | 38.7M | 35.9M | 34.6M | 33.7M | 32.6M | 30.3M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -17.0B | 2.26B | -6.01B | -16.5B | -538.5M | 7.50B | 9.18B | 5.01B | -3.70B | -4.34B |
| Capital spending | -20.2B | -2.17B | -587.5M | -1.54B | -3.76B | -25.2B | -3.07B | -7.07B | -1.47B | -6.98B |
| Free cash flow | -37.2B | 87.5M | -6.60B | -18.1B | -4.30B | -17.7B | -4.06B | -2.06B | -5.16B | -11.3B |
| Cash from investing | -19.7B | 5.18B | 8.52B | -12.4B | -26.8B | -14.7B | -4.63B | 654.9M | -9.98B | |
| Cash from financing | 19.2B | -58.0M | 1.67B | 2.99B | 33.0B | 7.88B | -2.10B | -1.75B | 12.1B | |
| Share buybacks | 140.0M | 1.09B | 3.60B | 4.45B | 2.11B | |||||
| Change in cash | 18.7B | 1.84B | -920.5M | -6.46B | -10.0B | 13.7B | 2.39B | -1.69B | -4.89B | -2.17B |
Cap table
Built by 6ix from Hyundai Bioscience Co. Ltd.’s releases
- Common shares
- 96,503,316
- Fully diluted
- 96,503,316
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 96,503,316 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 96,503,316 |
Log in to ask 6ix AI your own questions about Hyundai Bioscience Co. Ltd.